Atossa Therapeutics Inc. (ATOS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Atossa Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.37
−0.42% today
Market cap
$24M
Overall quality
56/100
Kronos AI 30-day
−1.3%
3 of 8 simulated paths end higher
Atossa Therapeutics Inc. (ATOS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $24M. It trades at $2.37, down 0.42% today. Its overall quality score is 56 out of 100, ranked against the whole US market. 2 analysts' average target of $17.50 implies +638.4% from today's price. Kronos AI's 30-day forecast is −1.3% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $17.50 |
| Low – high | $10.00 – $25.00 |
| Analysts | 2 |
| Upside to average | +638.4% |
Kronos AI 30-day forecast
| Expected close | $2.35 (−1.3%) |
| Likely range | −6.9% … +3.3% |
| As of | 2026-10-27 |
3 of 8 simulated paths end higher.
Quality scores
| Profitability | 38 |
| Solvency | 92 |
| Growth | 39 |
| Overall | 56 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.